Pra health sciences, inc. (PRAH)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Cash flows from operating activities:
Net income

239,523

243,119

239,425

158,272

159,499

154,458

67,156

113,908

101,284

87,293

117,513

100,356

109,368

68,175

82,654

74,864

48,609

81,765

30,441

7,957

-8,514

-35,742

-52,865

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense

119,568

114,898

113,546

112,553

112,516

112,247

112,244

102,827

90,374

78,227

67,406

66,261

67,745

69,506

71,981

74,035

75,670

77,952

81,641

85,783

91,161

96,564

98,473

0

0

0

Amortization of debt issuance costs

1,787

1,814

1,856

1,940

2,025

2,111

2,247

2,217

2,160

2,108

2,399

3,054

3,720

4,433

4,675

5,040

5,529

5,983

6,181

6,130

5,952

5,737

5,986

0

0

0

Amortization of terminated interest rate swaps

6,472

6,538

6,628

6,824

7,003

7,146

7,231

7,116

6,930

6,684

6,558

6,117

5,590

4,961

0

0

0

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

52,012

45,834

39,081

35,608

32,091

29,143

25,399

21,078

16,985

12,616

9,813

8,029

7,493

7,067

6,582

6,530

6,005

5,276

4,372

3,727

3,350

3,467

2,861

0

0

0

Gain (Loss) on Extinguishment of Debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-38,178

0

0

0

-

-

-

-

-25,036

-8,595

0

0

0

Change in fair value of acquisition-related contingent consideration

574

0

1,670

44,222

46,116

34,538

108,761

65,210

63,351

74,969

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

0

Non-cash transaction related stock-based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

42,166

0

0

0

-

-

-

-

-

-

-

-

-

Unrealized foreign currency gains, net

3,288

6,467

10,949

484

10,206

3,307

-4,163

-15,387

-32,565

-39,700

-20,287

-6,272

22,320

24,499

14,095

17,236

1,201

16,464

22,255

26,109

26,241

12,222

-341

0

0

0

Equity in income of unconsolidated joint ventures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Deferred income tax benefit

-31,910

-23,907

-31,242

-26,436

-14,677

11,665

-31,076

-58,986

-56,480

-75,915

-29,733

-2,063

-263

-10,469

-9,082

-10,520

-15,286

-3,219

-15,059

-13,466

-22,207

-31,968

-41,102

0

0

0

Other reconciling items

-819

-606

-770

73

384

-30

-625

-253

-537

-763

456

-346

610

605

2,282

837

1,528

-443

-3,067

-1,553

-3,085

-978

-608

0

0

0

Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:
Prepaid expenses and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accounts payable and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Advanced billings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accounts receivable, unbilled services and advanced billings

60,056

89,304

109,054

72,053

29,345

17,017

96,999

36,300

97,191

136,330

30,906

105,131

77,588

31,313

202,141

196,208

150,024

83,211

-110,488

-83,316

-83,283

32,781

62,682

0

0

0

Other operating assets and liabilities

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

Payment of acquisition-related contingent consideration

-

-

-

-

-

35,029

35,029

35,029

35,029

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

273,123

253,567

197,210

237,797

336,200

329,792

301,157

291,662

265,822

220,408

211,167

151,932

128,852

160,047

146,934

146,523

169,421

152,428

104,777

67,251

77,767

34,034

-22,480

0

0

0

Purchase of fixed assets

75,859

74,294

77,004

70,235

61,963

55,880

62,117

65,849

67,158

61,318

46,773

37,576

32,977

33,143

32,436

33,294

33,342

32,814

34,366

32,513

29,149

27,323

23,902

0

0

0

Proceeds from the sale of fixed assets

52

26

0

0

0

-

-

-

-

56

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

(Cash paid) proceeds received for interest on interest rate swap, net

529

-667

-1,132

-1,345

-936

-181

-14

591

872

874

763

897

952

913

0

0

0

-

-

-

-

-

-

-

-

-

Proceeds from RPS Parent Holding Corp. working capital settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Distributions from unconsolidated joint ventures

0

418

418

418

418

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition of Care Innovations, Inc., net of cash acquired

0

-

-

-

0

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-235,414

-73,183

-75,428

-68,238

-60,383

-55,473

-127,556

-655,332

-693,282

-687,420

-607,075

-74,902

-30,316

-34,614

-14,690

-69,677

-76,663

-71,686

-91,678

-35,269

-28,298

-11,472

-1,022,887

0

0

0

Cash flows from financing activities:
Proceeds from issuance of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from accounts receivable financing agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

Borrowings on line of credit

333,800

233,800

0

0

0

-

-

-

-

-

-

-

-

110,000

0

0

0

-

-

-

-

105,000

115,000

0

0

0

Repayments of line of credit

200,000

145,000

0

0

0

-

-

-

-

-

-

-

-

110,000

0

0

0

-

-

-

-

-

-

-

-

0

Repayments of long-term debt

1,222,783

1,216,533

134,999

209,999

217,197

224,394

213,033

124,283

124,897

125,513

715,875

704,625

696,813

822,559

133,559

143,559

158,559

40,000

342,100

334,325

321,550

308,775

573,738

0

0

0

Proceeds from common stock issued, net of underwriters discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payment of common stock issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

525

0

0

0

-

-

-

-

-

Proceeds from stock issued under employee stock purchase plan and stock option exercises

38,308

45,819

42,289

43,905

39,558

31,382

20,052

6,669

8,430

7,236

6,474

3,099

1,664

655

692

420

107

81

0

0

0

-

-

-

-

-

Payment of debt prepayment and debt extinguishment costs

-

-

-

-

-

-

-

-

-

-

-

-

-

17,824

0

0

0

-

-

-

-

-

-

-

-

-

Payment of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments for debt issuance costs

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payment of acquisition-related contingent consideration

-

-

-

-

-

79,663

79,663

79,663

80,063

400

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Principal repayments of fixed assets purchased under a financing agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by financing activities

-59,938

-90,707

-66,848

-150,749

-224,476

-319,512

-238,283

372,089

429,156

507,009

452,820

-63,793

-77,016

-101,595

-50,691

-40,963

-58,276

-42,444

-10,325

-24,037

-39,242

-5,956

1,096,912

0

0

0

Effects of foreign exchange changes on cash, cash equivalents, and restricted cash

-4,530

1,884

-979

-144

-4,360

-2,988

-1,761

152

3,849

3,555

1,788

823

477

-625

-750

-2,450

-1,746

-3,702

-6,013

-6,866

-6,949

-5,992

-2,291

0

0

0

Change in cash, cash equivalents, and restricted cash

-26,759

91,561

53,955

18,666

46,981

-48,181

-66,443

8,571

5,545

43,552

58,700

14,060

21,997

23,213

80,803

33,433

32,736

34,596

-3,239

1,079

3,278

10,614

49,254

0

0

0